Skip to main content
. 2016 May 5;6:25487. doi: 10.1038/srep25487

Figure 4.

Figure 4

Panel (A): Accuracy of the CLIF-C ACLFs (red line) as compared to MELDs (green) and MELD-Nas (orange) in predicting 28-day and 90-day mortality of patients with ACLF associated to cirrhosis due to HBV infection. Comparison of the areas under the ROC curves (AUROCs) estimated for each score. The CLIF-C ACLFs showed a significantly higher predictive ability in comparison with the MELDs and MELD-Nas scores for both the 28-day and 90-day mortality. Panel (B): Accuracy of the CLIF-C ADs (red line) as compared to MELDs (green) and MELD-Nas (orange) in predicting 6-month and 1-year mortality of patients with AD (without ACLD) due to HBV associated cirrhosis. Comparison of the AUROCs estimated for each score. The CLIF-C ADs showed significantly higher predictive ability in comparison to the MELDs.